← Eichor
Study identifier: NCT07019727 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

ESSKA/ESMA ACL Injury Prevention Program in Czech Sport

Condition: Double Leg Vertical Jump (DLVJ) · Single Leg Squat (SLS) · Single Leg Drop Landing (SLDL)  ·  Sponsor: Masaryk University

PhaseNA
Planned participants100
Who can joinAll sexes, 17 Years to 20 Years
Healthy volunteersYes

About this study

This study aims to address the rising incidence of ACL injuries, particularly among adolescents, by developing and implementing a comprehensive prevention program based on the evidence-based "ACL Prevention for ALL" framework recommended by ESSKA-ESMA. The project focuses on muscle strengthening, flexibility, coordination, proper movement techniques, and a multidisciplinary approach involving coaches, physiotherapists, and physicians. Through targeted exercise modules, education, and dynamic evaluation-including 2D motion analysis-the study seeks to reduce ACL injuries, enhance movement safety, and enable individualized training plans by identifying and correcting muscle and biomechanical imbalances.

This description comes directly from the study's public registry record.

Talk to the study team

Michael Lujc, MUDr.  ·  722101065  ·  lujc.michael@fnbrno.cz

Filip Huceček, MUDr.  ·  filip.hudecek@fnusa.cz

Always discuss trial participation with your own doctor first.

Locations (1)

Faculty of Medicine, Masaryk UniversityBrno, CzechiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07019727